Gasińska T, Wawrzyniak L
I Kliniki Chorób Wewnetrznych Slaskiej AM. Katowicach.
Pol Tyg Lek. 1994;49(1-3):43-5.
Abnormalities of carbohydrate metabolism have been frequently reported in hyperthyroid patients. Disturbed glucose tolerance might be due to increased hepatic glucose production, altered insulin metabolism, increased response to beta-adrenergic stimuli and elevated plasma FFA levels. These disturbances very often disappear when remission of thyrotoxicosis is attained during-treatment with thyrostatic drugs. Non-selective or selective beta 1-adrenoceptor blocking agents does not impair the glucose stimulated insulin secretion or the carbohydrate tolerance and impaired glucose tolerance disappear when glycolytic blockade is attained.
甲状腺功能亢进患者中碳水化合物代谢异常的情况屡有报道。糖耐量受损可能归因于肝脏葡萄糖生成增加、胰岛素代谢改变、对β-肾上腺素能刺激的反应增强以及血浆游离脂肪酸水平升高。在使用抗甲状腺药物治疗期间,当甲状腺毒症缓解时,这些紊乱情况常常会消失。非选择性或选择性β1-肾上腺素能受体阻滞剂不会损害葡萄糖刺激的胰岛素分泌或碳水化合物耐受性,并且当达到糖酵解阻滞时,受损的糖耐量会消失。